Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Darbepoetin alfa × Clear all

Phase

Status

Completed 41 Terminated 4 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

pembrolizumab 504 Specimen Handling 414 Carboplatin 380 Magnetic Resonance Spectroscopy 371 Cisplatin 354 Cyclophosphamide 337 Radiotherapy 310 Gemcitabine 268 Bevacizumab 260 Paclitaxel 252 Biopsy 242 Drug Therapy 237 Blood Specimen Collection 210 Nivolumab 199 venetoclax 198 fludarabine 197 Capecitabine 192 Oxaliplatin 189 Docetaxel 183 Injections 175 Fluorouracil 166 Radiosurgery 156 Dexamethasone 155 Pemetrexed 139 Rituximab 135 Standard of Care 134 Surgical Procedures, Operative 126 durvalumab 123 atezolizumab 122 tislelizumab 119

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07130487 2025-11-25

Project CARE: CAncer Risk Evaluation

Rutgers, The State University of New Jersey

Phase NA Recruiting

Primary Care

Data powered by HemOnc (CC BY 4.0) Colophon ⚡